Moderna
MRNA
#1332
Rank
$13.26 B
Marketcap
$34.30
Share price
-2.03%
Change (1 day)
-67.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2024 : $14.14 Billion USD

According to Moderna 's latest financial reports the company's total assets are $14.14 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2024-12-31$14.14 B-23.25%
2023-12-31$18.42 B-28.74%
2022-12-31$25.85 B4.82%
2021-12-31$24.66 B236.23%
2020-12-31$7.33 B361.61%
2019-12-31$1.58 B-19%
2018-12-31$1.96 B80.93%
2017-12-31$1.08 B-23.47%
2016-12-31$1.41 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$93.76 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$117.10 B 728.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.42 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.23 B-70.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$102.24 B 623.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$1.01 B-92.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$180.10 B 1,173.54%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA